The circuitry of protein tyrosine phosphorylation underlies many fundamental cellular processes, such as signal transduction, cell division, and growth control. The primary components of these circuits are protein tyrosine kinases (PTKs) and protein tyrosine phosphotases (PTPs). A broad outline of the complex interplay between these enzymes is understood, but the details of this relationship, particularly regarding the PM, are only beginning to emerge. The PTP gene family encodes two major classes of enzyme a large, transmembrane, receptor-type molecules and smaller, intracellular forms. While most attention has been devoted to the regulation and role of transmembrane, receptor PTPs, relatively little is known about their more abundant intracellular counterparts. TV goal of this study is to examine the mechanisms by which an abundant, prototypic intracellular PTP (PTP1B) is regulated and to explore its possible role as a tumor suppressor. Two preliminary observations hint at the mechanisms by which PTP1B may be regulated a) PTP1B is extraordinary sensitive to proteolysis, resulting in the generation of a smaller, more hydrophilic enzyme with different biological effects than its parent molecule; and, b) PTP1B undergoes cell-cycle specific phosphorylation. Using pulse-chase metabolic labeling, we will examine whether cells transiently transfected with PTP1B generate the truncated form, and, if so, if this form has a different specific activity than the full-length enzyme. To determine the functional consequences of the observed phosphorylation of PTP1B, we will examine whether the phosphorylated and unphosphorylated forms of PTP1B differ in cellular location and specific activity. We will also attempt to uncover the kinase(s) and phosphatase(s) that act upon PTP1B, as well as map the site(s) of phosphorylation. The possible role of PTP1B as a tumor suppressor will be explored using an steroid-inducible PTP expression system we have established in NIH-3T3 cells. When PTP1B expression is induced, these cells resist neoplastic transformation by v-src oncogene. We will examine PTP1B-expressing, v-src transfected NIH-3T3 cells for the loss of particular phosphotyrosyl proteins and/or expression of genes known to be induced by v-src. To determine whether PTP expression can revert an established malignancy, we will transfect a PTP expression vector into v-src transformed cells. We will also determine whether PTP1B expression prevents transformation by a variety of other PTK and non-PTK oncogenes. We anticipate that the insight we gain concerning the regulation and role of PTP1B will fill an important gap in our understanding of protein tyrosine phosphorylation. The results of the proposed experiments may also elucidate which key elements among the myriad changes in cellular physiology that occur as the result of PTK oncogene expression are required for the transformation process.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
3R01CA058836-05S1
Application #
2739050
Study Section
Chemical Pathology Study Section (CPA)
Program Officer
Spalholz, Barbara A
Project Start
1993-01-01
Project End
1998-07-31
Budget Start
1997-01-01
Budget End
1998-07-31
Support Year
5
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Institute for Cancer Research
Department
Type
DUNS #
872612445
City
Philadelphia
State
PA
Country
United States
Zip Code
19111
Rawat, Sonali J; Araiza-Olivera, Daniela; Arias-Romero, Luis E et al. (2016) H-ras Inhibits the Hippo Pathway by Promoting Mst1/Mst2 Heterodimerization. Curr Biol 26:1556-1563
Radu, Maria; Semenova, Galina; Kosoff, Rachelle et al. (2014) PAK signalling during the development and progression of cancer. Nat Rev Cancer 14:13-25
Saha, Sayanti; Chernoff, Jonathan (2014) Analysis of PTP1B sumoylation. Methods 65:201-6
Kelly, Mollie L; Astsaturov, Artyom; Rhodes, Jennifer et al. (2014) A Pak1/Erk signaling module acts through Gata6 to regulate cardiovascular development in zebrafish. Dev Cell 29:350-9
Arias-Romero, Luis E; Villamar-Cruz, Olga; Huang, Min et al. (2013) Pak1 kinase links ErbB2 to ?-catenin in transformation of breast epithelial cells. Cancer Res 73:3671-82
Arias-Romero, Luis E; Chernoff, Jonathan (2013) Targeting Cdc42 in cancer. Expert Opin Ther Targets 17:1263-73
Huynh, Nhi; Yim, Mildred; Chernoff, Jonathan et al. (2013) p-21-Activated kinase 1 mediates gastrin-stimulated proliferation in the colorectal mucosa via multiple signaling pathways. Am J Physiol Gastrointest Liver Physiol 304:G561-7
Radu, Maria; Rawat, Sonali J; Beeser, Alexander et al. (2013) ArhGAP15, a Rac-specific GTPase-activating protein, plays a dual role in inhibiting small GTPase signaling. J Biol Chem 288:21117-25
Rawat, Sonali Jalan; Creasy, Caretha L; Peterson, Jeffrey R et al. (2013) The tumor suppressor Mst1 promotes changes in the cellular redox state by phosphorylation and inactivation of peroxiredoxin-1 protein. J Biol Chem 288:8762-71
Kosoff, Rachelle; Chow, Hoi Yee; Radu, Maria et al. (2013) Pak2 kinase restrains mast cell Fc?RI receptor signaling through modulation of Rho protein guanine nucleotide exchange factor (GEF) activity. J Biol Chem 288:974-83

Showing the most recent 10 out of 36 publications